Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cyteir Therapeutics, Inc. | Chief Financial Officer | Common Stock | 102K | $173K | $1.69 | Mar 4, 2024 | Direct |
Cyteir Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 83.1K | Mar 4, 2024 | Direct | ||
Imunon, Inc. | Chief Financial Officer | Common Stock | 0 | Jun 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMNN | Imunon, Inc. | Jun 1, 2024 | 0 | $0 | 3 | Jun 10, 2024 | Chief Financial Officer |
SNSE | Sensei Biotherapeutics, Inc. | May 10, 2024 | 0 | $0 | 3 | May 16, 2024 | Principal Financial Officer |
CYT | Cyteir Therapeutics, Inc. | Feb 29, 2024 | 6 | $17.5K | 4 | Mar 5, 2024 | Chief Financial Officer |
CYT | Cyteir Therapeutics, Inc. | Dec 11, 2023 | 4 | $6.73K | 4 | Dec 14, 2023 | Chief Financial Officer |
CYT | Cyteir Therapeutics, Inc. | Nov 20, 2023 | 4 | $124K | 4 | Nov 22, 2023 | Chief Financial Officer |
CYT | Cyteir Therapeutics, Inc. | Feb 3, 2023 | 2 | $7.45K | 4 | Feb 7, 2023 | Chief Financial Officer |
CYT | Cyteir Therapeutics, Inc. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | Vice President, Finance |
CYT | Cyteir Therapeutics, Inc. | Dec 20, 2021 | 2 | $6.89K | 4 | Feb 7, 2023 | Chief Financial Officer |
CYT | Cyteir Therapeutics, Inc. | Jun 17, 2021 | 0 | $0 | 3 | Jun 17, 2021 | Vice President, Finance |